Lista de

vasculotropin
35
"Galectin-1 expression imprints a neurovascular phenotype in proliferative retinopathies and delineates responses to anti-VEGF" (2017) Ridano, M.E.;Subirada, P.V.;Paz, M.C. (...)Sánchez, M.C. Oncotarget. 8(20):32505-32522
"Tankyrase inhibition regulates corpus luteum development and luteal function in gonadotropin-treated rats" (2017) Accialini, P.;Irusta, G.;Bechis, A. (...)Tesone, M. Molecular Reproduction and Development. 84(8):719-730
"Angiotensin-(1-7) counteracts the transforming effects triggered by angiotensin II in breast cancer cells" (2017) Cambados, N.;Walther, T.;Nahmod, K. (...)Schere-Levy, C. Oncotarget. 8(51):88475-88487
"Phototriggered fibril-like environments arbitrate cell escapes and migration from endothelial monolayers" (2016) Salierno, M.J.;García-Fernandez, L.;Carabelos, N. (...)Campo, A.D. Biomaterials. 82:113-123
"Thyroid hormones and their membrane receptors as therapeutic targets for T cell lymphomas" (2016) Cremaschi, G.A.;Cayrol, F.;Sterle, H.A. (...)Barreiro Arcos, M.L. Pharmacological Research. 109:55-63
"Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet" (2016) Hockl, P.F.;Wolosiuk, A.;Pérez-Sáez, J.M. (...)Rabinovich, G.A. Pharmacological Research. 109:45-54
"Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model" (2015) Di Pietro, M.;Parborell, F.;Irusta, G. (...)Abramovich, D. Endocrinology. 156(4):1453-1463
"Classical and non-classical thyroid hormone intracellular pathways involved in T lymphoma growth" (2015) Arcos, M.L.B.;Sterle, H.;Cayrol, F. (...)Cremaschi, G.A. Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry. 15(1):37-42
"Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome" (2014) Scotti, L.;Abramovich, D.;Pascuali, N. (...)Parborell, F. Journal of Steroid Biochemistry and Molecular Biology. 144(PART B):392-401
"Platelet-derived growth factor BB and DD and angiopoietin1 are altered in follicular fluid from polycystic ovary syndrome patients" (2014) Scotti, L.;Parborell, F.;Irusta, G. (...)Abramovich, D. Molecular Reproduction and Development. 81(8):748-756
"Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors" (2014) Croci, D.O.;Cerliani, J.P.;Dalotto-Moreno, T. (...)Rabinovich, G.A. Cell. 156(4):744-758
"Metformin decreases the incidence of ovarian hyperstimulation syndrome: An experimental study" (2013) Elia, E.M.;Quintana, R.;Carrere, C. (...)Pustovrh, M.C. Journal of Ovarian Research. 6(1)
"Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas" (2012) Shan, B.;Schaaf, C.;Schmidt, A. (...)Renner, U. Journal of Endocrinology. 214(3):389-398
"Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome" (2012) Abramovich, D.;Irusta, G.;Bas, D. (...)Tesone, M. Endocrinology. 153(7):3446-3456
"A natural antiviral and immunomodulatory compound with antiangiogenic properties" (2012) Bueno, C.A.; Lombardi, M.G.; Sales, M.E.; Alché, L.E. Microvascular Research. 84(3):235-241
"Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas" (2011) Luque, G.M.;Perez-Millán, M.I.;Ornstein, A.M. (...)Becu-Villalobos, D. Journal of Pharmacology and Experimental Therapeutics. 337(3):766-774
"Modulation of endothelial cell migration and angiogenesis: A novel function for the "tandem-repeat" lectin galectin-8" (2011) Cárdenas Delgado, V.M.;Nugnes, L.G.;Colombo, L.L. (...)Elola, M.T. FASEB Journal. 25(1):242-254
"Direct survival role of vascular endothelial growth factor (VEGF) on rat ovarian follicular cells" (2010) Irusta, G.; Abramovich, D.; Parborell, F.; Tesone, M. Molecular and Cellular Endocrinology. 325(1-2):93-100
"VEGF and CD31 association in pituitary adenomas" (2010) Cristina, C.;Perez-Millan, M.I.;Luque, G. (...)Becu-Villalobos, D. Endocrine Pathology. 21(3):154-160
"Invasive giant prolactinoma with loss of therapeutic response to cabergoline: Expression of angiogenic markers" (2009) Mallea-Gil, M.S.;Cristina, C.;Perez-Millan, M.I. (...)Becu-Villalobos, D. Endocrine Pathology. 20(1):35-40
"The role of GnRH analogues in endometriosis-associated apoptosis and angiogenesis" (2008) Tesone, M.; Bilotas, M.; Barañao, R.I.; Meresman, G. Gynecologic and Obstetric Investigation. 66(SUPPL 1):10-18
"Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model" (2008) Quintana, R.;Kopcow, L.;Marconi, G. (...)Paz, D.A. Fertility and Sterility. 90(4 SUPPL):1511-1516
"Different kinases regulate activation of voltage-dependent calcium channels by depolarization in GH3 cells" (2007) Vela, J.; Pérez-Millán, M.I.; Becu-Villalobos, D.; Díaz-Torga, G. American Journal of Physiology - Cell Physiology. 293(3):C951-C959
"Estradiol Stimulates Vascular Endothelial Growth Factor and Interleukin-6 in Human Lactotroph and Lactosomatotroph Pituitary Adenomas" (2004) Onofri, C.;Carbia Nagashima, A.;Schaaf, L. (...)Arzt, E. Experimental and Clinical Endocrinology and Diabetes. 112(1):18-23
"Transforming growth factor-β stimulates vascular endothelial growth factor production by folliculostellate pituitary cells" (2002) Renner, U.;Lohrer, P.;Schaaf, L. (...)Stalla, G.K. Endocrinology. 143(10):3759-3765
"Relationship of ovarian stimulation response with vascular endothelial growth factor and degree of granulosa cell apoptosis" (2001) Quintana, R.;Kopcow, L.;Marconi, G. (...)Barañao, R.I. Human Reproduction. 16(9):1814-1818